MCID: HYP071

Hypersensitivity Reaction Type Ii Disease malady

Summaries for Hypersensitivity Reaction Type Ii Disease

Sources:
6Disease Ontology, 23MedlinePlus, 22MalaCards
See all sources

Export this MalaCard
MedlinePlus: Your body's immune system protects you from disease and infection. but if you have an autoimmune disease, your immune system attacks healthy cells in your body by mistake. autoimmune diseases can affect many parts of the body. these diseases tend to run in families. women - particularly african-american, hispanic-american, and native-american women - have a higher risk for some autoimmune diseases. there are more than 80 types of autoimmune diseases, and some have similar symptoms. this makes it hard for your health care provider to know if you really have one of these diseases, and if so, which one. getting diagnosed can be frustrating and stressful. in many people, the first symptoms are being tired, muscle aches and low fever. the diseases may also have flare-ups, when they get worse, and remissions, when they all but disappear. the diseases do not usually go away, but symptoms can be treated.23

MalaCards: Hypersensitivity Reaction Type Ii Disease, also known as autoimmune diseases, is related to rheumatoid arthritis and multiple sclerosis. An important gene associated with Hypersensitivity Reaction Type Ii Disease is TRAC (T cell receptor alpha constant), and among its related pathways are Cell adhesion molecules (CAMs) and Lymphocyte Signaling. The drugs prednisone and prednisone pwdr [va product] and the compounds glucose and ionomycin have been mentioned in the context of this disorder. Affiliated tissues include t cells, and related mouse phenotypes are respiratory system and craniofacial.

Disease Ontology: An immune system disease that is an overactive immune response of the body against substances and tissues normally present in the body resulting from an abnormal functioning of the immune system that results in the production of antibodies or t cell directed against the host tissues.6

Aliases & Descriptions for Hypersensitivity Reaction Type Ii Disease

Sources:
6Disease Ontology, 8DISEASES, 17Genetics Home Reference, 32Novoseek , 23MedlinePlus, 43UMLS, 24MeSH, 19ICD9CM
See all sources

Aliases & Descriptions:

hypersensitivity reaction type ii disease 6 8
autoimmune diseases 17 32 23 43
hypersensitivity reaction mediated by antibody 43
autoimmune disease 6

External Ids:

ICD9CM19 720

Related Diseases for Hypersensitivity Reaction Type Ii Disease

Sources:
13GeneCards, 14GeneDecks
See all sources

Disease types for hypersensitivity reaction type ii disease family:

hypersensitivity reaction type iii disease hypersensitivity reaction type iv disease

Diseases related to hypersensitivity reaction type ii disease by text searches and GeneDecks gene sharing:

(show top 50)    (show all 1021)
idRelated DiseaseScoreTop Affiliating Genes
1rheumatoid arthritis32.8IL1RN, HLA-DRB1, TNFRSF1A, CRP, LTA, PRTN3
2multiple sclerosis31.1MOG, CD40, IL1A, IL1B, IL1RN, IL2RA
3arthritis31.0SELL, SERPINA1, IL17A, IL1A, IL1B, IL6
4bullous pemphigoid30.3CD79A, ITGAL, IL13, IL5, IL7, CCL5
5primary biliary cirrhosis29.4SELL, VDR, BGLAP, CD79A, CD40LG, ITGAL
6celiac disease28.8MIF, IL6, HLA-DQB1, HLA-DRB1, TNF, CTLA4
7addison's disease28.6VDR, BGLAP, MRAP, CD79A, FOXP3, INS
8autoimmune polyendocrine syndrome28.6INS, IL17A, AIRE, TPO, TG, GAD2
9hepatitis28.5SELP, SERPINA1, GZMB, FASLG, FAS, IFNA1
10vogt-koyanagi-harada disease28.4CD8A, MIF, IL17A, IL2RA, FASLG, FAS
11cold agglutinin disease28.2MS4A1, IL6, TNF, CRP
12primary sclerosing cholangitis28.1MPO, AIRE, HLA-A, HLA-C, CTSG, LTF
13reactive arthritis27.8CD79A, HSPD1, HLA-B, TRH, CRP, LTF
14venous thrombosis27.7VWF, SELP, ITGAM, F8, HLA-B, CTSG
15acute promyelocytic leukemia27.6NCAM1, BCL2, MPO, ITGAL, PTPN3, PTPRC
16autoimmune thyroiditis27.6CD80, CD40, ITGAL, IL2RA, IL4, FASLG
17selective iga deficiency disease27.5CD79A, CD40LG, IL10, IL4, LTA
18heparin-induced thrombocytopenia27.3SELE, SELP, CD79A, CD40LG, ALB
19gamma chain deficiency27.2IL13, IL2, IL21, IL2RA, IL4, IL7
20leprosy27.1VDR, IL10, HLA-DQB1, HLA-DRB1, LTA, TLR2
21myeloproliferative disorder27.1VWF, SELP, BCR, MPO, IFNA1, PTPN11
22dermatitis herpetiformis26.9SELE, CD79A, CD40LG, ITGAM, IL13, IL2RA
23antiphospholipid syndrome26.9VWF, SELE, SELP, VCAM1, CD79A, CD40LG
24hypoparathyroidism26.9VDR, BGLAP, INS, IL2RA, ALPP, AIRE
25collagen disease26.8VWF, IL10, IL2RA, IL6, IFNG, TNF
26vitiligo26.7VDR, MPO, CD79A, CD8A, CD4, FOXP3
27interstitial lung disease26.3ITGAM, IL1A, IL1RN, IL8, CCL2, CCL5
28pemphigus foliaceus26.1CD79A, CD40LG, CD19, CD40, IL10, IL1A
29malaria26.1CD40LG, IL10, IL1A, IL4, IFNG, TNF
30wilson disease25.9SERPINA1, B2M, CD79A, IL1A, IL1B, IL1RN
31guillain-barre syndrome25.9MOG, CD79A, CD40LG, CD1D, IL10, FAS
32asthma25.8MPO, IL13, IL1B, IL4, CCL2, CCR5
33juvenile rheumatoid arthritis25.7BGLAP, IL1A, IL1RN, IL2RA, IL6, HSPD1
34optic neuritis25.7SAG, MOG, CD86, CD40LG, CD80, IL10
35localized scleroderma25.7CD40LG, IL13, IL2RA, IL4, IL8, CCL5
36pulmonary alveolar proteinosis25.6VDR, IL10, IL1B, IL5, IL8, CCL2
37type 1 diabetes mellitus25.5VDR, BGLAP, B2M, CD79A, CD69, INS
38thymoma25.5BCL2, LCK, B2M, MS4A1, MPO, CD2
39turner syndrome25.5VDR, BGLAP, CD79A, CD40LG, FOXP3, INS
40mixed connective tissue disease25.2CD40LG, INS, IL6, HSPG2, HSPD1, HLA-A
41hepatitis c24.7SERPINA1, CD28, CD69, CD40LG, IL10, IL18
42autoimmune hemolytic anemia24.6VWF, MPO, CD79A, CD40LG, IL10, IL17A
43microscopic polyangiitis24.5SELE, MPO, IL10, IL2RA, HLA-B, HLA-DQB1
44crohn's disease24.5MPO, CD80, FOXP3, MIF, IL10, IL13
45systemic lupus erythematosus24.4VWF, SELE, VCAM1, BCR, LCK, MPO
46paralysis24.4MOG, MIF, INS, IL10, IL1B, MBP
47systemic scleroderma24.2VWF, SELE, SELL, VCAM1, CD28, CD86
48graft versus host disease24.2SELL, CD28, ITGAL, GZMB, IL10, IL13
49cicatricial pemphigoid24.1CD79A, MIF, IL1A, IL1B, IL1RN, IL4
50wegener's granulomatosis24.1VWF, SELE, SERPINA1, VCAM1, MPO, CD28

Graphical network of the top 20 diseases related to hypersensitivity reaction type ii disease:



Graphical network of diseases related to hypersensitivity reaction type ii disease

Clinical Features for Hypersensitivity Reaction Type Ii Disease

Drugs & Therapeutics for Hypersensitivity Reaction Type Ii Disease

Sources:
4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT
See all sources

Approved drugs:

Search CenterWatch for hypersensitivity reaction type ii disease

Drug clinical trials:

Search ClinicalTrials for hypersensitivity reaction type ii disease

Search NIH Clinical Center for hypersensitivity reaction type ii disease

Search CenterWatch for hypersensitivity reaction type ii disease

Inferred drug relations via UMLS/NDF-RT:

43 28 methylprednisolone, methylprednisolone acetate, methylprednisolone sodium succinate, prednisone, prednisone pwdr [va product]

Genetic Tests for Hypersensitivity Reaction Type Ii Disease

Anatomical Context for Hypersensitivity Reaction Type Ii Disease

Sources:
22MalaCards
See all sources

MalaCards organs/tissues related to hypersensitivity reaction type ii disease:

22
T cells

Phenotypes for genes affiliated with Hypersensitivity Reaction Type Ii Disease

Sources:
25MGI
See all sources

MGI Mouse Phenotypes related to hypersensitivity reaction type ii disease:

25 (show all 25)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1respiratory system phenotypeMP:000538810.7SELL, SELP, CD1D, ALPL, PTPN22, PTPRC
2craniofacial phenotypeMP:000538210.2CSF2, PTPN11, HSPG2, ALPL, IL17A, FOXP3
3renal/urinary system phenotypeMP:00053679.9SOD2, PLG, PTPRC, TNFRSF1B, TNFRSF13B, INS
4hematopoietic system phenotypeMP:00053979.7ALPL, ADAMTS13, C5AR1, HLA-C, HLA-DQB1, TNFRSF13B
5endocrine/exocrine gland phenotypeMP:00053799.5SELL, CD40LG, IL2, FASLG, IFNG, AIRE
6no phenotypic analysisMP:00030129.5CCR5, ICOS, AIRE, HLA-C, PTPN3, PTPN11
7other phenotypeMP:00053959.0CSF2, SOD2, CXCR3, TLR2, TNFRSF1A, HSPG2
8liver/biliary system phenotypeMP:00053709.0PTPRC, CTLA4, CTSG, PLG, TLR2, TLR4
9skeleton phenotypeMP:00053908.9TNFRSF1B, PTPN3, PTPN11, PTPRC, CYCS, CTLA4
10digestive/alimentary phenotypeMP:00053818.7VWF, VDR, BCL2, BCR, PLG, TLR2
11integument phenotypeMP:00107718.6IFNG, TNFRSF1A, TNFRSF1B, PTPN11, CTLA4, TLR2
12nervous system phenotypeMP:00036318.4CD86, CD8A, CD4, CD1D, CD80, CD19
13adipose tissue phenotypeMP:00053758.0WDTC1, TLR2, TLR4, TGFB1, SOD2, CSF2
14normal phenotypeMP:00028737.3PTPN3, TNFRSF17, HLA-DQB1, AIRE, ALPP, ALB
15growth/size phenotypeMP:00053787.2HSPG2, GGT1, GAD2, CSF2, TG, HSPD1
16mortality/agingMP:00107687.1WDTC1, KLRK1, TSHR, TLR2, TLR4, PRF1
17immune system phenotypeMP:00053876.8VWF, MIF, FCGR1A, IL2, IL23A, IL6
18muscle phenotypeMP:00053696.5HLA-DQB1, TNF, TNFRSF1A, TNFRSF1B, PTPN11, PLAT
19reproductive system phenotypeMP:00053896.2VDR, B2M, CD44, TLR4, TGFB1, SOD2
20behavior/neurological phenotypeMP:00053865.8CYCS, TNFRSF1B, TNFRSF1A, HLA-DQB1, HLA-C, AIRE
21tumorigenesisMP:00020065.6IL5, IL6, FASLG, FAS, CCL2, CCR5
22vision/eye phenotypeMP:00053915.4TNFRSF1A, TNF, AIRE, HSPG2, ICAM1, IFNG
23homeostasis/metabolism phenotypeMP:00053764.9ALB, WDTC1, TSHR, TLR2, TLR4, TG
24cardiovascular system phenotypeMP:00053853.6VWF, SELE, SELL, SELP, VDR, VCAM1
25cellular phenotypeMP:00053843.1VWF, SELE, SELL, SELP, VDR, VCAM1

Publications for genes affiliated with Hypersensitivity Reaction Type Ii Disease

Expression for genes affiliated with Hypersensitivity Reaction Type Ii Disease

Sources:
1BioGPS
See all sources
Expression patterns in normal tissues for genes affiliated with Hypersensitivity Reaction Type Ii Disease

Pathways for genes affiliated with Hypersensitivity Reaction Type Ii Disease

Sources:
20KEGG, 3Cell Signaling Technology, 36QIAGEN, 37R&D Systems, 38Reactome
See all sources

Pathways related to hypersensitivity reaction type ii disease according to GeneDecks:

(show top 50)    (show all 147)
idPathwayScoreTop Affiliating Genes
1Cell adhesion molecules (CAMs)2010.4NCAM1, SELL, SELP, CD276, CD28, CD2
2Lymphocyte Signaling310.4NCAM1, LCK, B2M, CD8A, CD4, CD34
3RAR-Gamma-RXR-Alpha Degradation3610.3CD2, CD80, IL2, IL21, IL23A, IL7
4Antigen processing and presentation2010.1CD8A, CD4, HSPA4, HLA-C, HLA-DPB1, HLA-DQB1
5IL-15 Signaling and its Primary Biological Effects in Different Immune Cell Types379.7BCL2, GZMB, IL2, IL2RA, FASLG, TNFRSF1A
6Graft-versus-host disease209.6CD28, CD86, CD80, IL1A, IL2, FASLG
7Immune System389.6NCAM1, VCAM1, CD79A, CD34, CD40, FCGR1A
8Viral myocarditis209.4CD28, CD86, CD40LG, CD80, CD40, ITGAL
9Staphylococcus aureus infection209.3SELP, ITGAL, ITGAM, FCGR1A, IL10, ICAM1
10NFAT Signaling and Lymphocyte Interactions369.2BCL2, CD2, CD4, CD80, IL13, IL1A
11Regulation of eIF4 and p70S6K369.0CD2, CD4, CD80, ITGA4, ITGAL, ITGAM
12Molecular Mechanisms of Cancer369.0BCL2, CD2, CD4, CD80, ITGA4, ITGAL
13IL-6 Pathway368.8CD2, CD80, IL10, IL18, IL23A, IL4
14Natural killer cell mediated cytotoxicity208.5LCK, ITGAL, GZMB, FASLG, FAS, IFNA1
15Hematopoietic cell lineage208.2MS4A1, CD2, CD8A, CD4, CD34, CD1D
16PGC1Alpha Pathway368.1BCL2, CD2, CD4, CD80, IL13, IL18
17IL-21 Signaling and its Primary Biological Effects in Different Immune Cell Types378.1GZMB, IL17A, IL1B, IL21, IL23A, IL4
18Th1 Differentiation378.1CD28, CD86, CD4, CD80, IL10, IL18
19Asthma208.0CD40LG, CD40, IL10, IL13, IL4, IL5
20IL-2 Signaling and its Primary Biological Effects in Different Immune Cell Types377.7FOXP3, IL10, IL2, IL2RA, FASLG, FAS
21T cell receptor signaling pathway207.7LCK, CD28, CD8A, CD4, CD40LG, IL10
22Endothelin-1 Signaling Pathway367.7CD2, CD80, IL10, IL13, IL18, IL1A
23Akt Signaling367.7CD28, CD2, CD4, CD80, ITGAL, ITGAM
24Toxoplasmosis207.5BCL2, CD40LG, CD40, IL10, CCR5, IFNG
25THC Differentiation Pathway367.2CD28, CD86, IL10, IL18, IL2, IL2RA
26ERK Signaling367.0CD2, CD80, ITGA4, ITGAL, ITGAM, FN1
27Leishmaniasis207.0ITGA4, ITGAM, FCGR1A, IL10, IL1A, IL1B
28Rheumatoid arthritis207.0CD28, CD86, CD80, ITGAL, IL17A, IL18
29Tec Kinases Signaling367.0BCL2, CD28, CD2, CD4, CD80, ITGA4
30Autoimmune thyroid disease206.9CD28, CD86, CD40LG, CD80, CD40, GZMB
31Rho Family GTPases366.8BCL2, CD2, CD80, ITGA4, ITGAL, ITGAM
32Type I diabetes mellitus206.8CD28, CD86, CD80, GZMB, INS, IL1A
33Malaria206.8SELE, SELP, VCAM1, CD40LG, CD40, ITGAL
34SOCS Pathway366.6BCL2, CD2, CD4, CD80, INS, IL10
35Influenza A206.6IL18, IL1A, IL1B, IL6, IL8, FASLG
36TGF-Beta Pathway366.6BCL2, CD2, CD4, CD80, IL10, IL13
37Chagas disease (American trypanosomiasis)206.4IL10, IL1B, IL2, IL6, IL8, FASLG
38all-trans-Retinoic Acid Signaling in Brain366.4BCL2, CD2, CD80, IL10, IL13, IL18
39Allograft rejection206.3CD28, CD86, CD40LG, CD80, CD40, GZMB
40MIF Mediated Glucocorticoid Regulation366.1BCL2, CD2, CD80, MIF, IL10, IL13
41MIF Regulation of Innate Immune Cells366.1BCL2, CD2, CD80, MIF, IL10, IL13
42PEDF Induced Signaling366.1BCL2, CD2, CD80, IL10, IL13, IL18
43Tuberculosis206.1VDR, BCL2, ITGAM, FCGR1A, IL10, IL18
44PAK Pathway366.0BCL2, CD2, CD80, IL10, IL13, IL18
45MAPK Family Pathway365.8BCL2, CD2, CD4, CD80, IL10, IL13
46JAK-STAT Pathway365.8BCL2, CD2, CD4, CD80, IL10, IL13
47Cytokine Network365.8IL10, IL13, IL18, IL1A, IL1B, IL2
48Antioxidant Action of Vitamin-C365.7BCL2, CD28, CD2, CD4, CD80, IL10
49p38 Signaling365.7BCL2, LCK, CD28, CD2, CD4, CD80
50Cytokine-cytokine receptor interaction205.0CD40LG, CD40, IL10, IL13, IL17A, IL18

Compounds for genes affiliated with Hypersensitivity Reaction Type Ii Disease

Sources:
32Novoseek , 42Tocris Bioscience, 34PharmGKB, 9DrugBank, 18HMDB
See all sources

Compounds related to hypersensitivity reaction type ii disease according to GeneDecks:

(show top 50)    (show all 447)
idCompoundScoreTop Affiliating Genes
1glucose32 10.9CD2, GZMB, MIF, TRH, CTSG, PLG
2ionomycin32 10.5LCK, CD2, CD69, CD40, IL5, IL7
3dmso32 10.3SELP, ITGAM, ALPP, HSPG2, HSPA4, TNFRSF1A
4sp 60012532 42 11.3VCAM1, CD40, IL13, IL17A, CYCS, TLR2
5fluvastatin32 34 9 9 13.0VWF, SELP, VCAM1, CD40, ITGAL, IL1A
612-o-tetradecanoylphorbol 13-acetate32 9.9NCAM1, LCK, CD4, CD34, CD44, ITGAM
7oxygen32 18 10.4SERPINA1, BCL2, BCR, LCK, SAG, MPO
8ascorbic acid32 18 10.4VDR, BGLAP, FTH1, CD40LG, ITGAM, IL1A
9glutamate32 9.4NCAM1, VDR, LCK, CD79A, CD4, CD40
10cuprophan32 9.4SELL, SELP, VCAM1, B2M, ITGAL, ITGAM
11calcitriol32 42 9 18 9 13.4VDR, BGLAP, B2M, CD44, ITGAL, ITGAM
12estrogen32 9.4VWF, SERPINA1, VDR, BGLAP, CD34, GZMB
13pge232 9.3SELE, VCAM1, SAG, CD69, CD86, CD4
14formaldehyde32 18 10.3VWF, SELE, SELL, SELP, B2M, MPO
15endotoxin32 9.2SELL, CD86, CD40, ITGAL, ITGAM, MIF
16doxorubicin32 34 9 9 12.1NCAM1, SELE, B2M, CD40LG, CD19, CD40
17heparin32 9 18 9 12.0NCAM1, VWF, SERPINA1, BGLAP, SAG, B3GAT1
18calcium32 9 18 9 12.0VWF, BGLAP, BCR, LCK, SAG, MS4A1
19dextran sulfate32 9.0SELE, SELL, SELP, MPO, CD4, CD40LG
20wortmannin32 42 10.0VCAM1, BCL2, CD28, CD2, CD86, CD80
21arachidonic acid32 9 18 9 11.5NCAM1, VWF, SELP, SERPINA1, CD69, CD4
22sulfasalazine32 9 9 10.1SELE, MPO, CD79A, CD40LG, IL1A, IL1B
23con a32 8.1CD28, CD79A, CD2, CD69, IL10, IL18
24allergens32 7.9CD79A, CD69, CD86, CD40LG, CD80, CD40
25norepinephrine32 9 18 9 10.9VWF, SELE, SELL, SELP, VCAM1, CD79A
26arginine32 7.9VWF, VDR, BGLAP, B3GAT1, CD79A, CD40LG
27methacholine32 9 9 9.9MPO, CD79A, ITGA4, IL13, IL17A, IL4
28fibrinogen32 7.8SELE, SELP, SERPINA1, VCAM1, CD79A, CD40LG
29groalpha32 7.6SELE, VCAM1, IL10, IL13, IL17A, IL18
30butyrate32 7.6RBP3, VDR, BCL2, B2M, MPO, CD86
31cisplatin32 34 9 9 10.5BGLAP, BCL2, B2M, MPO, CD40LG, CD44
32curcumin32 7.4VCAM1, BCL2, MIF, IL17A, IL18, IL1A
33lipoteichoic acid32 7.3SELE, IL10, IL18, IL1B, IL1RN, IL6
34histamine32 18 8.2NCAM1, VWF, SELE, SELL, SELP, VCAM1
35pdtc32 7.2SELE, VCAM1, BCL2, CD40, IL18, IL1A
36cholesterol32 9 18 9 10.2VWF, SELE, SELP, SERPINA1, VCAM1, BCR
37glatiramer acetate32 9 9 9.1MOG, IL10, IL13, IL2, IL4, IL5
38glutamine32 7.1NCAM1, VWF, RBP3, VDR, SAG, B2M
39mip 1alpha32 6.9IL10, IL13, IL1B, IL4, IL6, IL8
40creatinine32 6.9NCAM1, VWF, SELE, SELL, SELP, SERPINA1
41lipid32 6.8NCAM1, SELE, SERPINA1, VCAM1, BCR, LCK
42infliximab32 9 9 8.0SELE, BGLAP, ITGA4, IL10, IL17A, IL18
43genistein32 9 18 9 8.8SELE, SELL, SELP, VDR, VCAM1, BCL2
44simvastatin32 34 42 9 18 9 10.7VWF, SELE, SELL, SELP, VCAM1, BGLAP
45pentoxifylline32 9 9 7.5SELL, SELP, VCAM1, MPO, ITGA4, ITGAM
46il-1232 5.4CD86, CD40LG, IL10, IL13, IL18, IL1B
47cyclosporin a32 42 5.9VWF, SELP, VDR, BGLAP, SAG, B2M
48nitric oxide32 9 18 9 7.6NCAM1, VWF, RBP3, SELE, SELP, SERPINA1
49retinoic acid32 42 18 6.3NCAM1, VWF, RBP3, SELL, SELP, VDR
50dexamethasone32 42 34 9 9 5.9NCAM1, VWF, SELL, SELP, VDR, VCAM1

GO Terms for genes affiliated with Hypersensitivity Reaction Type Ii Disease

Sources:
12Gene Ontology
See all sources

Cellular components related to hypersensitivity reaction type ii disease according to GeneDecks:

(show all 13)
idNameGO IDScoreTop Affiliating Genes
1MHC class II protein complexGO:04261310.1HLA-DPB1, HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
2clathrin-coated endocytic vesicle membraneGO:03066910.0HLA-DRB5, HLA-DRB4, HLA-DRB1, HLA-DQB1, HLA-DPB1, FCGR1A
3integral to lumenal side of endoplasmic reticulum membraneGO:0715569.8HLA-DRB5, HLA-DRB4, HLA-DRB1, HLA-DQB1, HLA-DPB1, HLA-C
4ER to Golgi transport vesicle membraneGO:0125079.8HLA-DRB5, HLA-DRB4, HLA-DRB1, HLA-DQB1, HLA-DPB1, HLA-C
5membrane raftGO:0451219.4THY1, TLR4, PTPRC, TNFRSF1B, TNFRSF1A, TNF
6platelet alpha granule lumenGO:0310939.3TGFB1, PLG, ALB, F8, FN1, SERPINA1
7secretory granuleGO:0301419.0POMC, LTF, PLAT, CTSG, TRH, HSPD1
8cell surfaceGO:0099868.8TPO, TNF, TNFRSF1A, CTSG, PLAT, TLR2
9integral to plasma membraneGO:0058878.5C5AR1, HLA-DRB1, HLA-C, HLA-B, HLA-A, ICOS
10external side of plasma membraneGO:0098977.4CD44, SELL, VWF, NCAM1, SELP, VCAM1
11plasma membraneGO:0058867.1TLR2, HLA-DRB1, HLA-DQB1, HLA-DPB1, HLA-C, HLA-B
12extracellular regionGO:0055764.9POMC, CSF2, CXCL9, CXCL13, CXCL10, PRF1
13extracellular spaceGO:0056152.9TNF, GIF, HSPD1, HSPG2, ALPL, ALB

Biological processes related to hypersensitivity reaction type ii disease according to GeneDecks:

(show top 50)    (show all 90)
idNameGO IDScoreTop Affiliating Genes
1leukocyte migrationGO:05090010.4ITGAM, SELP, LCK, CD2, CD34, ITGA4
2leukocyte cell-cell adhesionGO:00715910.4SELP, SELE, VCAM1, CD40LG, ITGA4, CCL5
3T cell receptor signaling pathwayGO:05085210.4LCK, HLA-DRB5, CD4, PTPN22, HLA-DPB1, HLA-DQB1
4T cell activationGO:04211010.3FOXP3, HSPD1, CD80, CD8A, CD86, CD276
5T cell costimulationGO:03129510.3ICOS, HLA-DPB1, HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
6detection of bacteriumGO:01604510.3HLA-DRB1, HLA-B, HLA-DRB5, HLA-DRB4, CD1D, HLA-A
7cell surface receptor signaling pathwayGO:00716610.2CD28, IL2RA, PTPRC, TNFRSF25, TNFRSF13B, CXCL10
8positive regulation of interleukin-10 productionGO:03273310.2HSPD1, CD34, CD40LG, IL21, IL23A, IL4
9positive regulation of interleukin-12 productionGO:03273510.1CD40, TLR4, CD40LG, TLR2, HSPD1, IFNG
10positive regulation of interleukin-2 biosynthetic processGO:04508610.1IL1A, IL1B, CD80, CD4, CD28, CD86
11response to lipopolysaccharideGO:0324969.9FASLG, SELE, SELP, SERPINA1, FAS, IL13
12positive regulation of inflammatory responseGO:0507299.8TLR2, TNFRSF1A, IL21, IL2, TLR4, IL23A
13defense response to virusGO:0516079.7CXCL10, IFNG, CD86, BCL2, CD40, CXCL9
14regulation of immune responseGO:0507769.7HLA-B, TRAC, ITGA4, CD40, CD19, HLA-C
15positive regulation of isotype switching to IgG isotypesGO:0483049.6CD40, PTPRC, TBX21, IFNG, IL4, IL2
16B cell proliferationGO:0421009.6HSPD1, IL10, CD40, CD79A, BCL2, PTPRC
17positive regulation of peptidyl-tyrosine phosphorylationGO:0507319.6TLR4, CD4, IL6, IL5, INS, MIF
18negative regulation of T cell proliferationGO:0421309.5FOXP3, TGFB1, HLA-DRB5, HLA-DRB4, HLA-DRB1, IL10
19cellular response to mechanical stimulusGO:0712609.5CD40, TNFRSF10A, TNFRSF1A, IL1B, NFKB1, TLR4
20response to ethanolGO:0454719.5IL13, PRF1, TLR4, TNFRSF1A, TRH, CCL2
21platelet activationGO:0301689.4PLG, SERPINA1, F8, ALB, TGFB1, LCK
22B cell differentiationGO:0301839.3VCAM1, IL4, PTPRC, CD40LG, ITGA4, IL10
23positive regulation of B cell proliferationGO:0308909.3CD40LG, IL13, BCL2, IL2, IL4, CD40
24interferon-gamma-mediated signaling pathwayGO:0603339.1NCAM1, VCAM1, B2M, PTPN11, HLA-DRB5, HLA-DRB4
25positive regulation of T cell proliferationGO:0421029.1CD28, CD276, VCAM1, CD1D, PTPRC, IFNG
26humoral immune responseGO:0069599.1TNF, AIRE, LTA, IFNG, CCL2, IL7
27acute-phase responseGO:0069539.1SERPINA1, CRP, FN1, F8, IL6, IL1RN
28lipopolysaccharide-mediated signaling pathwayGO:0316639.0CCL5, IL18, TLR4, TNF, IL1B, TLR2
29signal transductionGO:0071659.0IL21, TNFRSF25, CD4, CD34, POMC, ITGAL
30positive regulation of interferon-gamma productionGO:0327299.0LTA, TNF, HSPD1, IL23A, IL2, CD40LG
31cellular response to organic cyclic compoundGO:0714079.0TGFB1, TNF, ALPL, CCL5, CCL2, IL1B
32positive regulation of MHC class II biosynthetic processGO:0453488.9IL4, CD40LG, IL10, TLR4, IFNG
33cellular response to lipopolysaccharideGO:0712228.9TLR4, IL10, TSPO, TNFRSF1B, ICAM1, IFNG
34negative regulation of growth of symbiont in hostGO:0441308.8TLR2, CTSG, TNF, IFNG, IL10, LTA
35positive regulation of interleukin-6 productionGO:0327558.8TLR2, IL1A, TLR4, TNF, HSPD1, IL6
36cell adhesionGO:0071558.7IL2, VCAM1, NCAM1, VWF, SELL, SELP
37positive regulation of nitric oxide biosynthetic processGO:0454298.6TLR4, TLR2, TNF, IFNG, IL1B, INS
38MAPK cascadeGO:0001658.3TGFB1, CCL5, CCR5, CCL2, IL1B, IL18
39negative regulation of apoptotic processGO:0430668.1TNF, BCL2, INS, HSPD1, CSF2, CD44
40positive regulation of NF-kappaB transcription factor activityGO:0510928.1CD40, IL1B, IL6, ICAM1, TNF, NFKB1
41cell-cell signalingGO:0072678.1POMC, IL18, IL17A, IL13, IL10, INS
42apoptotic processGO:0069158.0TNFRSF1B, TNFRSF25, DDX41, CYCS, NFKB1, TSPO
43response to hypoxiaGO:0016667.9TRH, FAS, IL1B, IL1A, IL18, BCL2
44response to glucocorticoid stimulusGO:0513847.9IL1B, PLAT, TNF, ALPL, CCL2, CCL5
45cytokine-mediated signaling pathwayGO:0192217.9NCAM1, VCAM1, B2M, CD44, FCGR1A, HLA-DRB1
46immune responseGO:0069557.5C5AR1, CSF2, CXCL9, CXCL13, CXCL10, TLR4
47response to drugGO:0424937.3LTA, BGLAP, BCL2, LCK, IL10, TNF
48anti-apoptosisGO:0069167.3TNFRSF18, TNF, CCL2, FAS, IL2, IL1B
49positive regulation of transcription from RNA polymerase II promoterGO:0459447.2TNFRSF1A, DDX41, NFKB1, TLR2, TLR4, TGFB1
50inflammatory responseGO:0069546.2TNFRSF1B, CXCL10, TLR2, NFKB1, IL17A, CCL5

Molecular functions related to hypersensitivity reaction type ii disease according to GeneDecks:

(show all 11)
idNameGO IDScoreTop Affiliating Genes
1tumor necrosis factor-activated receptor activityGO:00503110.4TNFRSF25, TNFRSF1B, TNFRSF1A, TNFRSF18, TNFRSF17, FAS
2coreceptor activityGO:01502610.4CCR5, CD80, CD4, CD8A, CD86, CD28
3glycoprotein bindingGO:00194810.2ITGAM, CD5, CD4, LCK, SELP, VWF
4receptor activityGO:00487210.1TNFRSF10A, TNFRSF13B, TNFRSF17, TNFRSF25, TLR2, TLR4
5transmembrane signaling receptor activityGO:0048889.9TLR4, TLR2, ICAM1, CD44, CD5, CD4
6heparin bindingGO:0082019.9CXCL13, LTF, CTSG, PTPRC, CCL5, CCL2
7chemokine activityGO:0080099.6CXCL9, CXCL13, CXCL10, CCL5, CCL2, IL8
8protease bindingGO:0020209.3TNFRSF1A, TNF, MBP, INS, CD28, BCL2
9growth factor activityGO:0080837.5TGFB1, IL7, IL6, IL5, IL4, IL2
10cytokine activityGO:0051256.4IL23A, IL4, IL5, IL6, IL7, FASLG
11protein bindingGO:0055154.3TNFRSF13B, NFKB1, LTF, WDTC1, TSHR, TLR2

Sources for Hypersensitivity Reaction Type Ii Disease

2CDC
11FMA
18HMDB
19ICD9CM
20KEGG
24MeSH
25MGI
27NCIt
28NDF-RT
31NINDS
32Novoseek
33OMIM
35PubMed
36QIAGEN
43UMLS